MRC Technology and NYU School of Medicine Collaborate
News Apr 23, 2015
MRC Technology and NYU School of Medicine have signed an agreement to develop an antibody for the prevention of inflammatory osteolysis (bone breakdown).
Drs Bruce Cronstein and Kathryn Moore of NYU School of Medicine have identified key proteins expressed on the surface of osteoclasts in the progression of inflammatory osteolysis. MRC Technology has extensive experience in antibody engineering and under the agreement will generate lead antibodies for testing in osteolysis models, before delivering a candidate antibody with acceptable efficacy in vivo.
Dr Nadim Shohdy, Director, Drug Discovery Partnerships at NYU School of Medicine said: “Osteolysis affects about 20% of patients with orthopaedic prostheses, resulting in implant loosening and the need for revision surgeries. By combining the expertise of NYU School of Medicine in this area with that of MRC Technology, a leader in the discovery and development of antibody drugs, we aim to develop efficacious antibodies for patients with osteolysis that currently have few therapy options.”
Dr John Kelly, Associate Director, Business Development, MRC Technology said: “NYU School of Medicine has done extensive research and holds various patents for inhibiting osteolysis. Combined with our successful track record in antibody development to create therapies for a number of debilitating conditions, we are positive that we can help bring new treatments to patients.”
Financial terms have not been disclosed.
Macrophage's Role in Maintaining Tattoos Could Hold Key to RemovalNews
Researchers have discovered that, though a tattoo may be forever, the skin cells that carry the tattoo pigment are not. Instead, the cells can pass on the pigment to new cells when they die. The study suggests ways to improve the ability of laser surgery to remove unwanted tattoos.READ MORE
New Causes of Cellular Decline in Prematurely Aging Kids DiscoveredNews
In a recent paper published in Cell Reports, Saint Louis University researchers have uncovered new answers about why cells rapidly age in children with a rare and fatal disease. The data points to cellular replication stress and a mistaken innate immune response as culprits, and the team found success in the laboratory in blocking these processes with vitamin D.READ MORE
Measuring Neutrophil Motility Could Lead to Accurate Sepsis DiagnosisNews
Mass. General researchers design device that rapidly diagnoses sepsis with more than 95 percent accuracy.READ MORE
Comments | 0 ADD COMMENT
International Conference on Neuroimmunology, Neurological disorders and Neurogenetics
Sep 26 - Sep 27, 2018